Term
|
Definition
CH 30 Antidepressant Agents
Selective Serotonin Reuptake Inhibitors (SSRIs)
|
Highly selective blockade of serotonin transporter (SERT), little effect on norepinephrine transporter (NET)
Acute increase of serotonergic synaptic activity, slower changes in several signaling pathways and neurotrophic activity
|
Well tolerated but cause sexual dysfunction (30-40%)
Depression in children
Loss of libido
GI effects, insomnia, weight gain
|
Major depression, anxiety disorders, panic disorder, obsessive compulsive disorder, post-traumatic stress disorder, perimenopausal vasomotor symptoms, eating disorder (bulimia)
|
|
| |
| |
| |
|
|
|
Term
|
Definition
CH 30 Antidepressant Agents
Selective Serotonin Reuptake Inhibitors (SSRIs)
|
Highly selective blockade of serotonin transporter (SERT), little effect on norepinephrine transporter (NET)
Acute increase of serotonergic synaptic activity, slower changes in several signaling pathways and neurotrophic activity
|
Well tolerated but cause sexual dysfunction (30-40%)
Depression in children
Loss of libido
GI effects, insomnia, weight gain
|
Major depression, anxiety disorders, panic disorder, obsessive compulsive disorder, post-traumatic stress disorder, perimenopausal vasomotor symptoms, eating disorder (bulimia)
|
|
| |
| |
| |
|
|
|
Term
|
Definition
CH 30 Antidepressant Agents
Selective Serotonin Reuptake Inhibitors (SSRIs)
|
Highly selective blockade of serotonin transporter (SERT), little effect on norepinephrine transporter (NET)
Acute increase of serotonergic synaptic activity, slower changes in several signaling pathways and neurotrophic activity
|
Well tolerated but cause sexual dysfunction (30-40%)
Depression in children
Loss of libido
GI effects, insomnia, weight gain
|
Major depression, anxiety disorders, panic disorder, obsessive compulsive disorder, post-traumatic stress disorder, perimenopausal vasomotor symptoms, eating disorder (bulimia)
|
|
| |
| |
| |
|
|
|
Term
|
Definition
CH 30 Antidepressant Agents
Selective Serotonin Reuptake Inhibitors (SSRIs)
|
Highly selective blockade of serotonin transporter (SERT), little effect on norepinephrine transporter (NET)
Acute increase of serotonergic synaptic activity, slower changes in several signaling pathways and neurotrophic activity
|
Well tolerated but cause sexual dysfunction (30-40%)
Depression in children
Loss of libido
GI effects, insomnia, weight gain
|
Major depression, anxiety disorders, panic disorder, obsessive compulsive disorder, post-traumatic stress disorder, perimenopausal vasomotor symptoms, eating disorder (bulimia)
|
|
| |
| |
| |
|
|
|
Term
|
Definition
CH 30 Antidepressant Agents
Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs)
|
Moderately selective blockade of NET and SERT Acute increase in serotonergic and adrenergic synaptic activity (otherwise like SSRIs)
|
Many of serotonergic adverse effects associated with SSRIs
Depression in children
Loss of libido
Noradrenergic effects: ↑BP, ↑HR,
CNS effects: insomnia, anxiety
|
Major depression, chronic pain disorders, fibromyalgia, perimenopausal symptoms
|
|
| |
|
|
|
Term
|
Definition
CH 30 Antidepressant Agents
Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs)
|
Moderately selective blockade of NET and SERT Acute increase in serotonergic and adrenergic synaptic activity (otherwise like SSRIs)
|
Many of serotonergic adverse effects associated with SSRIs
Depression in children
Loss of libido
Noradrenergic effects: ↑BP, ↑HR,
CNS effects: insomnia, anxiety
|
Major depression, chronic pain disorders, fibromyalgia, perimenopausal symptoms
|
|
| |
|
|
|
Term
|
Definition
CH 30 Antidepressant Agents
Tricyclic Antidepressants (TCAs)
|
Mixed and variable blockade of NET and SERT Lite SNRIs plus significant blockade of autonomic nervous system and histamine receptors
|
Anticholinergic effects: dry mouth, constipation, urinary retention, blurred bison, confusion
α-blocking effects: orthostatic hypotension H1 antagonism: weight gain, sedation
arrhythmias
|
Major depression not response to other drugs, chronic pain disorders, incontinence, obsessive compulsive disorder
|
|
|
|
Term
|
Definition
CH 30 Antidepressant Agents
5-HT2 Antagonists
|
Inhibition of 5-HT2A receptor Forms a metabolite (m-cpp) that blocks 5-HT2A,2C receptors
|
H1 receptor blockade: sedation,
α receptor blockade: orthostatic hypotension
GI effects
|
Major depression, used for sedation and hypnosis insomnia
|
|
|
|
Term
|
Definition
CH 30 Antidepressant Agents
Momoamine Oxidase Inhibitors (MAOIs)
|
Irreversible, nonselective blockade of MAO-A and MAO-B
|
Anticholinergic effects
Orthostatic hypotension and weight gain are most common highest rates of sexual effects of all antidepressants restlessness, insomnia
|
Major depression unresponsive to other drugs
|
|
|
|